Article Versions Notes

Geboers B, Timmer FEF, Ruarus AH, Pouw JEE, Schouten EAC, Bakker J, Puijk RS, Nieuwenhuizen S, Dijkstra M, van den Tol MP, et al. Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol. Cancers. 2021; 13(15):3902. https://doi.org/10.3390/cancers13153902

Geboers, Bart, Florentine E. F. Timmer, Alette H. Ruarus, Johanna E. E. Pouw, Evelien A. C. Schouten, Joyce Bakker, Robbert S. Puijk, Sanne Nieuwenhuizen, Madelon Dijkstra, M. Petrousjka van den Tol, and et al. 2021. "Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol" Cancers 13, no. 15: 3902. https://doi.org/10.3390/cancers13153902

Geboers, B., Timmer, F. E. F., Ruarus, A. H., Pouw, J. E. E., Schouten, E. A. C., Bakker, J., Puijk, R. S., Nieuwenhuizen, S., Dijkstra, M., van den Tol, M. P., de Vries, J. J. J., Oprea-Lager, D. E., Menke-van der Houven van Oordt, C. W., van der Vliet, H. J., Wilmink, J. W., Scheffer, H. J., de Gruijl, T. D., Meijerink, M. R., & on behalf of the Dutch Pancreatic Cancer Group. (2021). Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol. Cancers, 13(15), 3902. https://doi.org/10.3390/cancers13153902